21
Tae Kyoung Kim, Aqeel A Fatmi: Formulations of bisphosphonate drugs with improved bioavailability. Banner Pharmacaps, Charles T Joyner, June 22, 2006: US20060134190-A1

This invention relates to formulations of bisphosphonates such as alendronate. The formulations taught herein enhance bioavailability of bisphosphonates and reduce esophageal and gastric ulcerations associated with them. Also taught herein are methods of preparing the formulations and their clinical ...


22
Emadeldin M Hassan, Nachiappan Chidambaram, Aqeel A Fatmi: Controlled release preparation. Womble Carlyle Sandridge & Rice Pllc, June 1, 2006: US20060115527-A1

Controlled release preparations and capsules are provided. Also provided are emulsions and suspensions, including compositions and methods of manufacturing controlled release capsules, where the fill contains a suspension and/or an emulsion.


23
Karunakar Sukuru, Nachiappan Chidambaram, Aqeel A Fatmi: Non-blooming gelatin and non-gelatin formulations. Banner Pharmacaps, Patrea L Pabst, Pabst Patent Group, April 27, 2006: US20060088590-A1

A non-blooming plasticizer composition and methods of using the composition are described herein. The composition is a mixture of sorbitol and sorbitan wherein the ratio of sorbitan and sorbitol is between about 0.40 and about 1.2 by weight, more preferably from about 0.45-0.50 to about 0.70 by weig ...


24
Zhi Liu, Dana S Toops, Aqeel A Fatmi: Stable solutions of orlistat for pharmaceutical dosage forms. Banner Pharmacaps, Pabst Patent Group, April 8, 2010: US20100087520-A1

Liquid orlistat-containing fill materials suitable for encapsulating in hard or soft capsules are described herein. The fill material contains orlistat dissolved in one or more medium chain triglycerides or medium chain partial triglycerides, one or more citrate esters, and combinations thereof. The ...